Docplexus brings you an all-new, interesting weekly series of 30-minute talks on the pressing issues in global healthcare. Don't miss out on your " ClinShots ", every Tuesday, at 6:00 PM IST ! The majority of patients with asthma can achieve disease control with standard therapy. However, approximately 5-10% suffer from severe, inadequately controlled asthma. Biological therapy is a promising targeted therapeutic option for such patients with severe asthma.
These targeted therapies have been shown to reduce asthma exacerbations, improve lung function, reduce oral corticosteroid use, and improve the quality of life in selected patients. Join Dr. Sameer Bansal in our new series of exclusive sessions, ClinShots , on “ Role of Biologics in Severe Asthma ” on 23 rd August 2022, 6:00 PM IST onwards. ##Session highlights## Biologics and evidences Protocol and algorithms Case scenarios##…
